Showing results (811-820 of 1,663) with videos related to

Sort By:
Pageof 167
Vascular Health and Risk Management|July 19, 2026
Comparison of FINDRISC and the Framingham Model for Predicting CHD Risk: Results from the Kharameh Cohort StudyAndishe Hamedi, Mozhgan Seif, Mohammad Hossein Sharifi, et al.
Vascular Health and Risk Management|August 22, 2026
Associations of Patient Morphology and Venous Anatomy with Early Changes in Upper-Extremity Venous Blood Flow Following PICC Placement in Patients with Cancer: A Prospective Cohort StudyGuodong Wang, Yanfen Shen, Yuan Yang, et al.
Vascular Health and Risk Management|September 21, 2026
Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional StudyJing Huang, Zien Huang, Feng Huang
Vascular Health and Risk Management|September 20, 2026
Temporal Changes in Hospital-Captured 90-Day Care After Venous Thromboembolism: A 16-Year Electronic Health Record Cohort StudyYonghui Wang, Yan Wang, Xuemin Zhang, et al.
Vascular Health and Risk Management|December 5, 2014
Macitentan for the treatment of pulmonary arterial hypertensionCyrus A Kholdani, Wassim H Fares, Terence K Trow
Vascular Health and Risk Management|June 9, 2016
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumabDirk J Blom, Ricardo Dent, Rita C Castro, et al.
Vascular Health and Risk Management|June 29, 2013
Statins in heart failure: do we need another trial?Kwadwo Osei Bonsu, Amudha Kadirvelu, Daniel Diamond Reidpath
Vascular Health and Risk Management|July 23, 2013
The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patientsChristopher R Ellis, Daniel W Kaiser
Vascular Health and Risk Management|July 31, 2013
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective studyChadi Saifan, Elie El-Charabaty, Suzanne El-Sayegh
Vascular Health and Risk Management|November 23, 2013
Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular riskHong Lai, Elliot K Fishman, Gary Gerstenblith, et al.
Pageof 167